Market News AIOpen the app

RBC Capital says to keep buying GH Research, setting a price target of $42.

OpinionRead the original at moomoo.com
Neutral

RBC kept its Buy rating and $42 price target unchanged. This is an analyst's continuing opinion, not new information about GH Research's business, so the outlook is unchanged.

GHRS · GH Research

AI read · Neutral

The AI's read

The story adds no new results about GH Research or its drug studies. RBC's unchanged view is one firm's opinion, not a change in the company's business, so it does not change the outlook.

Get alerts for GHRS

Follow GH Research (GHRS) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for GHRS
Free on the App Store and Google Play, or on the web.